Concomitant prescribing of tranquilizers and hypnotics among patients receiving antidepressant prescriptions

Annals of Pharmacotherapy

Volumn 32, Issue 5, 1998, Pages 531-535

  Bingefors, Kerstin ^a,b   Isacson, Dag G L ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Antidepressants; Hypnotics; Prescribing; Tranquilizers

Indexed keywords

ALDEHYDE DERIVATIVE; ALPRAZOLAM; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMIC ACID DERIVATIVE; DIAZEPAM; HYPNOTIC AGENT; IMIDAZOPYRIDINE DERIVATIVE; MONOAMINE OXIDASE INHIBITOR; OXAZEPAM; PROPIOMAZINE; SEROTONIN UPTAKE INHIBITOR; TRANQUILIZER; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; AMBULATORY CARE; ARTICLE; DEPRESSION; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; OBSESSION; PANIC; PHOBIA; PREMENSTRUAL SYNDROME; PRESCRIPTION; PRIORITY JOURNAL; SWEDEN;

ADULT; AGED; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HEALTH CARE SURVEYS; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; SWEDEN; TRANQUILIZING AGENTS;

EID: 0031750766     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.17211     Document Type: Article

References (26)

1. Flint A. Epidemiology and comorbidity of anxiety disorders in the elderly. Am J Psychiatry 1994;15:640-9.
2. Bingefors K, Isacson D, von Knorring L, Smedby B, Ekselius L, Kupper L. Antidepressant-treated patients in ambulatory care: long-term use of non-psychotropic and psychotropic drugs. Br J Psychiatry 1996;168:292-8.
3. Joffe R, Levitt A, Sokolow S. Augmentation strategies: focus on anxiolytics. J Clin Psychiatry 1996;57(suppl 7):25-31.
4. Parkes A. Starting SSRI antidepressant therapy: its effect on tricyclic antidepressant and benzodiazepine prescribing (letter). Med J Aust 1996; 164:509.
5. Rascati K. Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications. Clin Ther 1995;17:786-90.
6. Gregor K, Riley J, Downing D. Concomitant use of anxiolytics and hypnotics with selective serotonin reuptake inhibitors. Clin Ther 1996;18: 521-7.
7. Boyer W. Potential indications for the selective serotonin reuptake inhibitors. Int Clin Psychopharmacol 1992;6(suppl 5):5-12.
8. Zung W, Magruder-Habib K, Velez R, Ailing W. The comorbidity of anxiety and depression in general medical inpatients: a longitudinal study. J Clin Psychiatry 1990;51:77-80.
9. Sherbourne C, Wells K, Meredith L, Jackson C, Camp P. Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch Gen Pract 1996;53:889-95.
10. Brown C, Schulberg H, Madonia M, Shear M, Houck P. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 1996;153:1293-300.
11. Bingefors KAL, Isacson DGL, von Knorring L, Smedby B. Prescription drug and healthcare use among Swedish patients treated with antidepressants. Ann Pharmacother 1995;29:566-72.
12. Isacson D, Bingefors K, Wennberg M, Dahlström M. Factors associated with high-quantity prescriptions of benzodiazepines in Sweden. Soc Sci Med 1993;36:343-51.
13. Wessling A. The National Prescription Survey. A data base for drug utilization studies in Sweden - results and experiences from the 1970s and 1980s (PhD thesis). Stockholm: Karolinska Institute, 1990.
14. Socialstyrelsen. Klassifikation av sjukdomar 1987 (Classification of diseases 1987). Stockholm: Liber/Allmänna Förlaget, 1987.
15. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 1990.
16. Apoteksbolaget AB. Svensk Läkemedelsstatistik 1996 (Swedish Drug Statistics). Stockholm: Apoteksbolaget AB, 1997.
17. SAS Institute Inc. SAS/STAT guide for personal computers (Version 6 ed). Cary, NC: SAS Institute, 1987.
18. SAS Institute Inc. Technical report P-229. Cary, NC: SAS Institute, 1992.
19. Rosholm J-U, Gram L, Damsbo N, Hallas J. Antidepressant treatment in general practice - an interview study. Scand J Prim Health Care 1995; 13:281-6.
20. Läkemedelsverket. Farmakoterapi vid depression (Pharmacotherapy in depression). Uppsala: Läkemedelsverket (Medical Products Agency), 1995:5.
21. Jacobsson L, von Knorring L, Perris C. En multiaspekt klassifikations-modell och dess användning av svenska psykiatrer (a multi-aspect classification model and its use by Swedish psychiatrists). Proceedings of the Swedish Psychiatric Association. Stockholm: 1978:vol II).
22. Depression Guideline Panel. Depression in primary care: volume I. Detection and diagnosis. Clinical practice guideline number 5. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Policy and Research, 1993.
23. Katona C. Depression in old age. Chichester, England: John Wiley, 1994.
24. Bingefors K, Isacson D, von Knorring L. Antidepressant dose patterns in Swedish clinical practice. Int Clin Psychopharmacol 1997;12:283-90.
25. Nichol M, Stimmel G, Lange S. Factors predicting the use of multiple psychotropic medications. J Clin Psychiatry 1995;56:60-6.
26. Tylee A. Depression Patient Research in European Society (DEPRES) study. Int J Methods Psychiatric Res 1996;6(suppl):S33-7.